Healthcare provider profile · identity verified

Jenny Phung-Payne, MD

Family Practice · LONG BEACH, CA · NPI 1659629905

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	337	176
Amlodipine Besylate	Amlodipine Besylate	231	123
Lisinopril	Lisinopril	228	112
Levothyroxine Sodium	Levothyroxine Sodium	160	71
Losartan Potassium	Losartan Potassium	144	79
Rosuvastatin Calcium	Rosuvastatin Calcium	127	59
Metformin Hcl Er	Metformin Hcl	116	59
Simvastatin	Simvastatin	108	41
Albuterol Sulfate Hfa	Albuterol Sulfate	105	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	58
Omeprazole	Omeprazole	94	61
Hydrochlorothiazide	Hydrochlorothiazide	88	47
Atenolol	Atenolol	83	37
Meloxicam	Meloxicam	83	47
Tramadol Hcl	Tramadol Hcl	83	21
Trazodone Hcl	Trazodone Hcl	74	41
Metoprolol Tartrate	Metoprolol Tartrate	68	35
Glipizide	Glipizide	67	34
Lorazepam	Lorazepam	67	24
Metformin Hcl	Metformin Hcl	67	38
Alendronate Sodium	Alendronate Sodium	63	29
Pantoprazole Sodium	Pantoprazole Sodium	63	21
Furosemide	Furosemide	58	38
Ozempic	Semaglutide	58	24
Pradaxa	Dabigatran Etexilate Mesylate	57	25
Gabapentin	Gabapentin	51	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	32
Ibuprofen	Ibuprofen	42	26
Terazosin Hcl	Terazosin Hcl	42	21
Azelastine Hcl	Azelastine Hcl	40	13
Potassium Chloride	Potassium Chloride	40	26
Wixela Inhub	Fluticasone Propion/Salmeterol	40	17
Bisoprolol Fumarate	Bisoprolol Fumarate	38	18
Jardiance	Empagliflozin	34	15
Triamcinolone Acetonide	Triamcinolone Acetonide	34	24
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Allopurinol	Allopurinol	33	17
Duloxetine Hcl	Duloxetine Hcl	32	18
Clopidogrel	Clopidogrel Bisulfate	30	15
Acetaminophen-Codeine	Acetaminophen With Codeine	29	13
Tamsulosin Hcl	Tamsulosin Hcl	29	19
Acyclovir	Acyclovir	28	suppressed
Famotidine	Famotidine	28	17
Humulin N	Insulin Nph Human Isophane	28	13
Methocarbamol	Methocarbamol	28	suppressed
Carvedilol	Carvedilol	27	15
Lovastatin	Lovastatin	27	14
Montelukast Sodium	Montelukast Sodium	27	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	17
Sertraline Hcl	Sertraline Hcl	26	13
Ezetimibe	Ezetimibe	25	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	13
Alprazolam	Alprazolam	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	12
Eliquis	Apixaban	20	11
Naproxen	Naproxen	20	14
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	19	16
Ondansetron Odt	Ondansetron	19	13
Prednisone	Prednisone	19	18
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Finasteride	Finasteride	16	suppressed
Alvesco	Ciclesonide	15	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Humulin R	Insulin Regular, Human	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Cefadroxil	Cefadroxil	14	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Colchicine	Colchicine	12	suppressed
Estradiol	Estradiol	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Lactulose	Lactulose	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error